BEIGENE (06160.HK) announced that according to US GAAP, the company expects to achieve positive operating income for the full ...

StockNews.com initiated coverage on shares of BeiGene (NASDAQ:BGNE – Free Report) in a research note issued to investors on Sunday. The brokerage issued a hold rating on the stock. Several other ...

The conversion of Calquence’s accelerated approval in mantle cell lymphoma comes a day before the drug was listed among the ...

David Li, an analyst from Bank of America Securities, maintained the Hold rating on BeiGene (ONC – Research Report). The associated price ...

This executive interview, sponsored by BeiGene, is with Jan-Henrik Terwey, Vice President, Medical Affairs Europe at BeiGene.

BeiGene ADR is working on a consolidation with a 248.16 entry. See if the stock can clear the breakout price in volume at ...

BeiGene stock just hit that mark, with a jump from 69 to 84 Wednesday. Is BeiGene Stock A Buy? BeiGene stock reclaimed its 50 ...

BeiGene (ONC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

ET Net News Agency, 15 January 2025] CCB International raised the target price for BeiGene (06160) to HKD179 from HKD173 and maintained the "outperform" rating. The research hous ...

Analyst Jill Wu of CMB International Securities maintained a Buy rating on BeiGene (ONC – Research Report), boosting the price target to ...

Stock analysts at StockNews.com initiated coverage on shares of BeiGene (NASDAQ:BGNE – Get Free Report) in a report released on Saturday. The brokerage set a “hold” rating on the stock. A number of ...

A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...